incretin mimetics glp 1 agonists PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: GLP-1 Receptor Incretin-Based Therapies Through the Decades:
Description
11 (Suppl
Diabetes 63 , 41864196 (2014)
doi: 10.1161/01.CIR.0000120505.91348.58
Molecules 28 (2), 751
According to the World Health Organization (WHO), over 422 million people globally live with diabetes, while obesity has nearly tripled since 1975, with more than 1 billion individuals affected, significantly increasing demand for effective GLP-1-based therapeutic interventions worldwide
The next wave of obesity medicine may include stronger, more complex metabolic therapies
